AI-powered cancer data hub to map tumor risk and treatment responses
Official title: Unveiling Cancer Risk Through AI-Powered Spatial Insights
Funded at Institute for Systems Biology · NIH-11450436 · Data updated 2026-11-12
A cancer-focused project will build an AI-driven data platform that combines genomic, transcriptomic, proteomic, and spatial data to better understand cancer risk and how tumors respond to treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute for Systems Biology NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $555,592 |
| NIH project number | 1R01CA309386-01A1 |
| Project ID | NIH-11450436 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer or those at risk who may contribute tissue samples or clinical data for future analyses.
✕Less likely to help
If your cancer type is not well represented in the integrated datasets or you are not a candidate for data sharing, direct benefits may be limited.
What this research studies
This project aims to create a harmonized, multi-modal resource that links clinical information with deep molecular data from many tumor types. Researchers will develop AI tools and a large histopathology database to enable easier, faster analysis of complex cancer datasets. The goal is to help clinicians and patients benefit from clearer insights into tumor biology, progression, and potential therapies as data from TCGA and other sources are integrated.
Why it matters
Potential benefit: If successful, it could lead to more personalized cancer risk assessments and more informed treatment decisions.
How similar studies have gone: Prior large-scale data-sharing efforts like TCGA have driven meaningful advances; this project aims to extend those gains with AI-powered integration.
Where this research is happening
-
Institute for Systems Biology
Seattle, United States Active
Researchers
- Principal investigator: Thorsson, Vesteinn — Institute for Systems Biology
- Study coordinator: Thorsson, Vesteinn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.